Melanie Sena

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

Alcon enters agreement with Google to in-license its "smart lens" technology for all ocular medical uses.

Lilly and Immunocore enter immunotherapy agreement to co-discover and co-develop new cancer therapies.

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

Handheld Analyzer Improves Accuracy

Research from Frost & Sullivan indicates a strong comeback of IPOs suggesting a positive outlook for investment in the pharmaceutical and biotechnology industry.

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.

GE Healthcare and Promosome sign a licensing agreement that gives GE Healthcare exclusive rights to a new suite of mammalian cell line development technologies.

Spectrum Pharmaceuticals appoints Joseph Turgeon as president and COO.

Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.

Grace's ProVance disposable Protein A chromatography column is designed for downstream purification.

OPUS technology designed to process large single-use bioreactor harvests.

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

FDA develops an assay that could speed the release of pandemic influenza vaccines.

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

Ben Venue issues a voluntary patient level recall of Acetylcysteine Solution 10% due to glass particle in vial.

Innovative Medicines Initiative will develop novel antibiotics against gram-negative pathogens in a project called ENABLE.

New medicines in development include treatments for type 1 and type 2 diabetes.

Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.

Shire appoints Susan Kilsby as its New Chairman.

Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.

Coldstream Laboratories names director of formulation development.